Alector Inc (ALEC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.56
• Market Cap: $260.87M
• EPS: $-1.06
• 52-Week High: $3.40
• 52-Week Low: $0.87

Market Sentiment

Alector Inc currently has a Neutral sentiment score of 0.04.

About Alector Inc

Alector, Inc. (ALEC) is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative conditions, including Alzheimer's disease and frontotemporal dementia. Utilizing its proprietary immuno-neurology platform, Alector aims to leverage the immune system to rejuvenate neuronal health and functionality. Based in South San Francisco, California, the company is at the forefront of research and development aimed at transforming treatment pa...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Alector Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ALEC pay dividends?

Alector Inc (ALEC) does not currently pay a regular dividend.

What is ALEC's market cap?

Alector Inc (ALEC) has a market capitalization of $260.87M with a current stock price of $2.56.